Kawasaki Disease News and Research

RSS
Kawasaki disease (also known as lymph node syndrome, mucocutaneous node disease, infantile polyarteritis and Kawasaki syndrome) is a disease, largely of infants, which affects many organs, including the skin, mucous membranes, lymph nodes, and blood vessel walls, but the most serious effect is on the heart where it can cause severe aneurysmal dilations.
New study explores post-COVID-19 inflammatory condition in children

New study explores post-COVID-19 inflammatory condition in children

PCORI approves up to $50 million in funding for new projects to address COVID-19

PCORI approves up to $50 million in funding for new projects to address COVID-19

GlobalData: Further research into MIS-C could reveal how COVID-19 affects the immune system

GlobalData: Further research into MIS-C could reveal how COVID-19 affects the immune system

GlobalData: COVID-19 effects on pregnancy remain uncertain and debatable

GlobalData: COVID-19 effects on pregnancy remain uncertain and debatable

New syndrome associated with SARS-CoV-2 is new and distinct from Kawasaki disease

New syndrome associated with SARS-CoV-2 is new and distinct from Kawasaki disease

Improving detection of SARS-CoV-2 infection among severely ill children

Improving detection of SARS-CoV-2 infection among severely ill children

Kawasaki-like inflammatory syndrome appears to be more common in children of African ancestry

Kawasaki-like inflammatory syndrome appears to be more common in children of African ancestry

Rare deadly disease linked to coronavirus infection seen in children

Rare deadly disease linked to coronavirus infection seen in children

Teens develop septic shock due to COVID-19

Teens develop septic shock due to COVID-19

Study presents early data on SARS‐CoV ‐2 testing, outcomes at Australian children’s hospital

Study presents early data on SARS‐CoV ‐2 testing, outcomes at Australian children’s hospital

FDA approves IND application by Octapharma USA for severe COVID-19 patients

FDA approves IND application by Octapharma USA for severe COVID-19 patients

Immunotherapy, steroids restore heart function in children with COVID-related multi-system inflammatory syndrome

Immunotherapy, steroids restore heart function in children with COVID-related multi-system inflammatory syndrome

Steroids and immunotherapy improve outcomes in children with COVID-related multi-system inflammatory syndrome

Steroids and immunotherapy improve outcomes in children with COVID-related multi-system inflammatory syndrome

Kawasaki disease outbreak in children with COVID-19

Kawasaki disease outbreak in children with COVID-19

Study finds children at greater risk for severe complications from COVID-19

Study finds children at greater risk for severe complications from COVID-19

COVID-19 could be causing potentially fatal inflammatory disease in children, doctors warn

COVID-19 could be causing potentially fatal inflammatory disease in children, doctors warn

Study shows ADA2 is a sensitive, specific biomarker for macrophage activation syndrome

Study shows ADA2 is a sensitive, specific biomarker for macrophage activation syndrome

As off-label use spreads, supplies of niche drugs and patients’ patience grow short

As off-label use spreads, supplies of niche drugs and patients’ patience grow short

Study provides evidence that enterovirus may be a factor in acute flaccid myelitis

Study provides evidence that enterovirus may be a factor in acute flaccid myelitis

Study identifies antigens targeted by antibody response to Kawasaki Disease

Study identifies antigens targeted by antibody response to Kawasaki Disease